enVVeno Medical (NVNO) Share-based Compensation (2017 - 2026)

enVVeno Medical's Share-based Compensation history runs 10 years deep, the most recent figure standing at $467000.0 for Q1 2026.

• On a quarterly basis, Share-based Compensation fell 28.26% year-over-year to $467000.0 in Q1 2026; TTM through Mar 2026 was $3.2 million, a 14.01% decrease from a year earlier, with the FY2025 full-year figure at $3.4 million, down 30.2% from the prior year.
• Share-based Compensation eased to $467000.0 in Q1 2026 per NVNO's latest filing, from $637000.0 in the prior quarter.
• Across five years, Share-based Compensation topped out at $3.7 million in Q3 2025 and bottomed at $467000.0 in Q1 2026.
• The 5-year median for Share-based Compensation is $1.1 million (2023), against an average of $1.5 million.
• Biggest YoY gain for Share-based Compensation was 1996.26% in 2022; the steepest drop was 58.11% in 2022.
• Year by year, Share-based Compensation stood at $2.2 million in 2022, then sank by 48.88% to $1.1 million in 2023, then decreased by 11.01% to $1.0 million in 2024, then sank by 37.43% to $637000.0 in 2025, then retreated by 26.69% to $467000.0 in 2026.
• Per Business Quant, the three latest NVNO Share-based Compensation figures stand at $467000.0 (Q1 2026), $637000.0 (Q4 2025), and $3.7 million (Q3 2025).